Stock Events

Stock Events

Daiichi Sankyo. 

$16.8
128
+$0.05+0.3% Tuesday 13:32

Statistics

Day High
16.8
Day Low
16.8
52W High
28.9
52W Low
15.75
Volume
1,500
Avg. Volume
-
Mkt Cap
31.83B
P/E Ratio
17.01
Dividend Yield
1.57%
Dividend
0.26

Upcoming

30
SEP
Dividend Ex
Estimated
 
10
DEC
Dividend Payment
Estimated
 
31
MAR 27
Dividend Ex
Estimated
 
30
SEP 27
Dividend Ex
Estimated
 
10
DEC 27
Dividend Payment
Estimated
 

Dividends

1.57%Dividend Yield
Mar 26
$0.25
Dec 25
$0.26
Jun 25
$0.2
Dec 24
$0.21
Jun 24
$0.2
10Y Growth
9.58%
5Y Growth
15.96%
3Y Growth
27.38%
1Y Growth
9.87%

Earnings

5AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.13
0.23
0.32
0.42
Expected EPS
0.419826
Actual EPS
N/A

Financials

15.69%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
25.43BRevenue
3.99BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DSKYF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company that competes with Daiichi Sankyo in various therapeutic areas, including oncology, cardiovascular health, and immunology.
Merck
MRK
Mkt Cap277.02B
Merck & Co. is a direct competitor in the pharmaceutical sector, particularly in oncology where both companies are investing heavily in cancer treatment research and development.
Novartis
NVS
Mkt Cap279.67B
Novartis is a leading pharmaceutical company that competes with Daiichi Sankyo in multiple areas, including cancer and cardiovascular diseases, with a strong emphasis on research and development.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, particularly in oncology, where it is a leading provider of cancer treatments alongside Daiichi Sankyo.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is a global biopharmaceutical company that competes with Daiichi Sankyo, especially in the oncology sector, where both companies have a strong pipeline of cancer drugs.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb is a competitor in the pharmaceutical industry, focusing on cancer, HIV/AIDS, cardiovascular, and immune system disorders, areas where Daiichi Sankyo also operates.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, competes with Daiichi Sankyo in areas such as oncology and immunology.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with Daiichi Sankyo in the pharmaceutical sector, including in the development and marketing of medications for cancer and infectious diseases.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with Daiichi Sankyo in various healthcare areas, including oncology, cardiovascular diseases, and diabetes, with a broad range of pharmaceutical products.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes with Daiichi Sankyo, particularly in the area of oncology, with both companies focusing on innovative cancer treatments and therapies.

About

There is no Profile data available for D4S.SG.
Show more...
CEO
Mr. Sunao Manabe D.V.M., Ph.D.
Employees
18726
Country
Japan
ISIN
JP3475350009

Listings

MX
MX
4568N.MX
OTC Link
US
DSNKY
STU
DE
D4S.STU
F
DE
D4S.F

0 Comments

Share your thoughts

FAQ

What is Daiichi Sankyo. stock price today?▼
The current price of DSKYF is $16.8 USD — it has increased by +0.3% in the past 24 hours. Watch Daiichi Sankyo. stock price performance more closely on the chart.
What is Daiichi Sankyo. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Daiichi Sankyo. stocks are traded under the ticker DSKYF.
Is Daiichi Sankyo. stock price growing?▼
DSKYF stock has risen by +1.08% compared to the previous week, the month change is a -6.82% fall, over the last year Daiichi Sankyo. has showed a -33.99% decrease.
What is Daiichi Sankyo. market cap?▼
Today Daiichi Sankyo. has the market capitalization of 31.83B
When is the next Daiichi Sankyo. earnings date?▼
Daiichi Sankyo. is going to release the next earnings report on August 05, 2026.
What were Daiichi Sankyo. earnings last quarter?▼
DSKYF earnings for the last quarter are 0.31 USD per share, whereas the estimation was 0.35 USD resulting in a -11.96% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Daiichi Sankyo. revenue for the last year?▼
Daiichi Sankyo. revenue for the last year amounts to 25.43B USD.
What is Daiichi Sankyo. net income for the last year?▼
DSKYF net income for the last year is 3.99B USD.
Does Daiichi Sankyo. pay dividends?▼
Yes, DSKYF dividends are paid semi-annual. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 1.57%.
How many employees does Daiichi Sankyo. have?▼
As of May 06, 2026, the company has 18,726 employees.
In which sector is Daiichi Sankyo. located?▼
Daiichi Sankyo. operates in the Health & Wellness sector.
When did Daiichi Sankyo. complete a stock split?▼
The last stock split for Daiichi Sankyo. was on September 29, 2020 with a ratio of 3:1.
Where is Daiichi Sankyo. headquartered?▼
Daiichi Sankyo. is headquartered in Chuo, Japan.